The call was for biomed scientists and investors to apply for a new startup focused on AI-designed antibody therapies.

Current cancer drugs target mechanisms that trigger tumor growth, but some tumors are still considered therapy-resistant. A recent study in Israel may lead to removing one more form of breast cancer from the "untreatable list."